April 23, 2013 6:04 am by Berkrot, Bill | 0 Comments
(Reuters) - A combination of three experimental Bristol-Myers Squibb hepatitis C drugs appeared to be highly effective, according to data from a mid-stage clinical trial, keeping the company in the ...
Read more
April 22, 2013 1:09 am by Berkrot, Bill | 1 Comments
In the past week, medical testing companies, such as Quest Diagnostics, medical device makers Johnson & Johnson and Abbott Laboratories, hospital operators, such as HCA Holdings Inc, and even diaper ...
Read more
March 10, 2013 4:24 pm by Berkrot, Bill | 0 Comments
SAN FRANCISCO (Reuters) - Gilead Sciences Inc's angina drug Ranexa reduced incidents of chest pain in patients with diabetes, and the effect appeared to be more pronounced in those with ...
Read more
February 13, 2013 6:27 pm by Berkrot, Bill | 0 Comments
(Reuters) - President Barack Obama's decision to spotlight drug rebates as a way to save money on Medicare is likely to be opposed by the pharmaceutical industry, which could potentially ...
Read more
February 7, 2013 9:21 am by Berkrot, Bill | 0 Comments
NEW YORK (Reuters) - Amgen Inc said it expects generic versions of biotech drugs, known as biosimilars, to be a multibillion-dollar opportunity for the company and has targeted some of ...
Read more
January 23, 2013 10:32 am by Berkrot, Bill | 0 Comments
(Reuters) - Celgene Corp said its Abraxane drug helped patients with advanced pancreatic cancer live an average of two months longer than chemotherapy and significantly increased the percentage of those ...
Read more
December 8, 2012 2:00 pm by Berkrot, Bill | 0 Comments
(Reuters) - A new blood clot preventer from Pfizer Inc and Bristol-Myers Squibb Co reduced the risk of recurrence of clots in veins and lungs and death by 80 percent ...
Read more
December 5, 2012 12:24 pm by Berkrot, Bill | 0 Comments
NEW YORK/TEL AVIV (Reuters) - Teva Pharmaceutical Industries' new Chief Executive Jeremy Levin has promised investors it will be a very different company going forward. Next week he has to ...
Read more
November 20, 2012 2:57 pm by Berkrot, Bill | 0 Comments
(Reuters) - European health regulators on Tuesday approved an eagerly anticipated blood thinner developed by Bristol-Myers Squibb Co and Pfizer Inc for the prevention of strokes and blood clots in ...
Read more
November 6, 2012 1:14 pm by Berkrot, Bill | 3 Comments
LOS ANGELES (Reuters) - Common visible signs of aging may not just be a vanity or employment problem. They may also be a harbinger of heart disease.In a large, long-term ...
Read more
November 4, 2012 7:52 pm by Berkrot, Bill | 0 Comments
LOS ANGELES (Reuters) - Diabetics with more than one diseased artery fared significantly better if they underwent bypass surgery than those who received drug coated stents following artery clearing procedures ...
Read more
October 29, 2012 7:59 am by Berkrot, Bill | 0 Comments
NEW YORK (Reuters) - Global drugmakers are paying tens of millions of dollars to settle U.S. allegations that they bribed their way across emerging markets, but harsher penalties may be ...
Read more
October 22, 2012 2:47 pm by Berkrot, Bill | 0 Comments
(Reuters) - The extended shutdown of a sister company of the pharmacy at the center of the deadly meningitis outbreak may exacerbate drug shortages for some hospitals and healthcare providers, ...
Read more
October 18, 2012 3:07 pm by Berkrot, Bill | 0 Comments
NEW YORK/LOS ANGELES (Reuters) - Health officials made their first confirmation of the presence of a deadly fungus in one of three lots of steroids tied to a national meningitis ...
Read more
October 16, 2012 6:00 pm by Berkrot, Bill | 0 Comments
(Reuters) - Intuitive Surgical Inc on Tuesday reported 22 percent growth in procedures using its da Vinci surgical robots in the third quarter that it said was below its estimate, ...
Read more
